Skip to main content
logo
Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
1.090
-0.020 (-1.80%)
At close: Jul 2, 2026, 4:00 PM EDT
1.097
+0.007 (0.63%)
After-hours: Jul 2, 2026, 6:23 PM EDT

Tempest Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1.817.7130.2739.2331.2351.83
Cash & Short-Term Investments
1.817.7130.2739.2331.2351.83
Cash Growth
-91.61%-74.54%-22.84%25.62%-39.74%175.39%
Other Current Assets
0.640.561.211.131.7217.13
Total Current Assets
2.458.2731.4740.3632.9568.96
Net Property, Plant & Equipment
7.798.159.5310.7912.714.16
Other Long-Term Assets
0.510.520.490.450.430.11
Total Assets
10.7516.9341.4951.646.0973.24
Accounts Payable
0.591.042.450.851.110.99
Accrued Expenses
1.491.084.553.334.7617.59
Current Portion of Long-Term Debt
--6.354.29--
Current Portion of Leases
1.241.190.870.951.411.44
Total Current Liabilities
3.313.3114.229.417.2820.03
Long-Term Debt
---6.2610.3715.07
Long-Term Leases
6.626.958.149.1610.332.03
Total Long-Term Liabilities
6.626.958.1415.4220.717.1
Total Liabilities
9.9310.2622.3624.8427.9837.12
Common Stock
0.010.0100.020.010.01
Additional Paid-in Capital
270.88240.03226.23192.01153.87136.17
Retained Earnings
-270.07-233.37-207.11-165.26-135.77-100.06
Shareholders' Equity
0.826.6719.1326.7718.1136.12
Total Liabilities & Equity
10.7516.9341.4951.646.0973.24
Total Debt
7.858.1415.3720.6622.1118.54
Net Cash (Debt)
-6.05-0.4314.918.579.1233.29
Net Cash Growth
---19.74%103.70%-72.62%103.24%
Net Cash Per Share
-1.00-0.106.9415.6610.26114.19
Book Value
0.826.6719.1326.7718.1136.12
Book Value Per Share
0.141.618.9122.5720.39123.87
Tangible Book Value
0.826.6719.1326.7718.1136.12
Tangible Book Value Per Share
0.141.618.9122.5720.39123.87
SEC Filings: 10-K · 10-Q